The use of alternative therapies to treat geriatric depression

ISRCTN ISRCTN93225273
DOI https://doi.org/10.1186/ISRCTN93225273
Secondary identifying numbers N/A
Submission date
29/03/2008
Registration date
29/05/2008
Last edited
29/05/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Samia Toukhsati
Scientific

School of Psychology, Psychiatry and Psychological Medicine
Building F
Caulfield Campus
Monash University
Melbourne
3145
Australia

Phone +61 (0)3 9903 2367
Email Samia.Toukhsati@med.monash.edu.au

Study information

Study designA multicentre, double-blind, nested, randomised controlled trial with three independent groups
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEvaluating the effects of music and animal-assisted therapy on depression in aged care residents
Study objectivesThe primary aim of this randomised clinical study is to evaluate the efficacy of two alternative therapies, music therapy (MT) and animal-assisted therapy (AAT), to reduce depressive symptomatology in cognitively intact elderly individuals residing in aged care facilities. A secondary aim of this study is to explore neurophysiological mechanisms that may underpin any observed effects of the alternative therapy interventions. The following hypotheses have been formulated on the basis of the above aims:
1. MT and AAT will improve quality of life and reduce the physical, cognitive, affective and interpersonal deficits associated with depression in the elderly to a greater extent than the no intervention control group
2. MT and AAT will produce observable changes in electroencephalogram (EEG) indices of depression to a greater extent than the no intervention control condition
3. Changes observed in psychological indices of depression will correlate with changes observed on physiological measures of depression
Ethics approval(s)Ethics approval received from the Monash University Standing Ethics Committee on Research Involving Humans (SCERH) on the 20th February 2008
Health condition(s) or problem(s) studiedDepression
InterventionExperimental conditions:
Music therapy and animal-assisted therapy will each be presented by accredited therapists twice weekly to small groups (N = 5) for four weeks, yielding a total of eight therapeutic sessions. Therapy session will last approximately 45 minutes. Music therapy will comprise listening to preferred music, singing, and playing percussion instruments. Animal-assisted therapy will comprise activities with a temperament-tested dog, such as patting, grooming, playful interaction and watching the animal perform tricks. Participants assigned to either treatment will continue to receive diversional activities already in place at their respective facilities.

Control condition:
The non-intervention control group will continue to receive diversional activities already in place at the respective facilities, but will not receive an additional treatment.

Post-intervention measures will be taken the week after the interventions have been completed and post-testing will take one week to complete per facility.
Intervention typeOther
Primary outcome measure1. Affective: symptoms of depression will be measured with the mood disorder module of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV (SCID-IV-TR) and the GDS
2. Cognitive: general cognitive status will be assessed using the SMMSE. The more specific domain of executive functioning will be assessed using the Trail Making Test Part A and B, Digit-Symbol Coding and the Controlled Oral Word Association Test (COWA).
3. General health and well-being: assessed using the Australia Quality of Life (AQoL) Scale. Pain will be assessed the Present Pain Index (PPI) and the Modified Cumulative Illness Rating Scale (MCIRS).

All outcomes will be measured over the course of four days prior to the four week intervention period and in the week following treatment.
Secondary outcome measuresNeurophysiological measures:
Two EEG components will be explored. First, previous research has indicated that depression is associated with relative left frontal asymmetry and that pharmacological and psychological treatment for depression may normalise this brain activity pattern. Second, abnormal P300 responses (such as reduced amplitude and increased latency) have also been observed in individuals with depression. Given these findings, this study will explore the effect of alternative therapies on the topographic distribution of spectral power and the amplitude and latency of the P300 evoked potential.

All outcomes will be measured over the course of four days prior to the four week intervention period and in the week following treatment.
Overall study start date01/06/2008
Completion date30/08/2009

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants150 in total
Key inclusion criteria1. Adults (65+ years), either sex
2. A score of at least 20 on the Standardised Mini Mental Status Examination (SMMSE)
3. A score of at least 5 on the Geriatric Depression Scale (GDS)
4. English fluency
Key exclusion criteria1. Diagnosis of dementia or delirium
2. Significant hearing or vision impairments
3. Unable to provide informed consent (due to mental status)
4. Placed in the facility within the previous three weeks
Date of first enrolment01/06/2008
Date of final enrolment30/08/2009

Locations

Countries of recruitment

  • Australia

Study participating centre

School of Psychology, Psychiatry and Psychological Medicine
Melbourne
3145
Australia

Sponsor information

Monash University (Australia)
University/education

School of Psychology, Psychiatry and Psychological Medicine
Building F
Caulfield Campus
Melbourne
3145
Australia

Phone +61 (0)3 9903 2367
Email Samia.Toukhsati@med.monash.edu.au
Website http://www.monash.edu.au
ROR logo "ROR" https://ror.org/02bfwt286

Funders

Funder type

Charity

J.O. & J.R. Wicking Trust (Australia and New Zealand [ANZ] Trustees) (Australia)

No information available

Monash University (Australia)
Government organisation / Universities (academic only)
Alternative name(s)
Monash Uni | Melbourne, Monash Uni, University of Monash, Universitas Monash, MU
Location
Australia

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan